Removal of domain D2 or D3 of the human urokinase receptor does not affect ligand affinity

Leena Riittinen; Paola Limongi; Massimo P. Crippa; Massimo Conese; Luciano Hernandez-Marrero; Francesca Fazioli; Francesco Blasi

doi:10.1016/0014-5793(96)00033-6

Removal of domain D2 or D3 of the human urokinase receptor does not affect ligand affinity

Leena Riittinen, Paola Limongi, Massimo P. Crippa, Massimo Conese, Luciano Hernandez-Marrero, Francesca Fazioli, Francesco Blasi

IRCCS Ospedale San Raffaele

Research output: Contribution to journal › Article › peer-review

Abstract

The main ligand-binding determinant of the human urokinase receptor (uPAR) is located in the amino terminal domain D1, but when isolated this domain presents a 1500 fold lower affinity than the intact three-domain uPAR (D1D2D3). uPAR mutants missing either domain 2 (D1HD3) or domain 3 (D1D2) were expressed in murine LB6 cells and showed to be properly GPI-anchored to the cell surface. Binding assays with [ ¹²⁵I]ATF demonstrated that these mutants possessed a normal (D1D2) or slightly reduced (D1HD3) affinity, indicating that a high ligand-affinity may be achieved by a combination of D1 with domain D2 or D3.

Original language	English
Pages (from-to)	1-6
Number of pages	6
Journal	FEBS Letters
Volume	381
Issue number	1-2
DOIs	https://doi.org/10.1016/0014-5793(96)00033-6
Publication status	Published - Feb 26 1996

Keywords

GPI-anchored protein
uPA
Urokinase receptor

ASJC Scopus subject areas

Biochemistry
Biophysics
Molecular Biology

Access to Document

10.1016/0014-5793(96)00033-6

Cite this

@article{6bc549bc4c8b447f8c9e33be79d107ec,

title = "Removal of domain D2 or D3 of the human urokinase receptor does not affect ligand affinity",

abstract = "The main ligand-binding determinant of the human urokinase receptor (uPAR) is located in the amino terminal domain D1, but when isolated this domain presents a 1500 fold lower affinity than the intact three-domain uPAR (D1D2D3). uPAR mutants missing either domain 2 (D1HD3) or domain 3 (D1D2) were expressed in murine LB6 cells and showed to be properly GPI-anchored to the cell surface. Binding assays with [ 125I]ATF demonstrated that these mutants possessed a normal (D1D2) or slightly reduced (D1HD3) affinity, indicating that a high ligand-affinity may be achieved by a combination of D1 with domain D2 or D3.",

keywords = "GPI-anchored protein, uPA, Urokinase receptor",

author = "Leena Riittinen and Paola Limongi and Crippa, {Massimo P.} and Massimo Conese and Luciano Hernandez-Marrero and Francesca Fazioli and Francesco Blasi",

year = "1996",

month = feb,

day = "26",

doi = "10.1016/0014-5793(96)00033-6",

language = "English",

volume = "381",

pages = "1--6",

journal = "FEBS Letters",

issn = "0014-5793",

publisher = "Elsevier",

number = "1-2",

}

TY - JOUR

T1 - Removal of domain D2 or D3 of the human urokinase receptor does not affect ligand affinity

AU - Riittinen, Leena

AU - Limongi, Paola

AU - Crippa, Massimo P.

AU - Conese, Massimo

AU - Hernandez-Marrero, Luciano

AU - Fazioli, Francesca

AU - Blasi, Francesco

PY - 1996/2/26

Y1 - 1996/2/26

N2 - The main ligand-binding determinant of the human urokinase receptor (uPAR) is located in the amino terminal domain D1, but when isolated this domain presents a 1500 fold lower affinity than the intact three-domain uPAR (D1D2D3). uPAR mutants missing either domain 2 (D1HD3) or domain 3 (D1D2) were expressed in murine LB6 cells and showed to be properly GPI-anchored to the cell surface. Binding assays with [ 125I]ATF demonstrated that these mutants possessed a normal (D1D2) or slightly reduced (D1HD3) affinity, indicating that a high ligand-affinity may be achieved by a combination of D1 with domain D2 or D3.

AB - The main ligand-binding determinant of the human urokinase receptor (uPAR) is located in the amino terminal domain D1, but when isolated this domain presents a 1500 fold lower affinity than the intact three-domain uPAR (D1D2D3). uPAR mutants missing either domain 2 (D1HD3) or domain 3 (D1D2) were expressed in murine LB6 cells and showed to be properly GPI-anchored to the cell surface. Binding assays with [ 125I]ATF demonstrated that these mutants possessed a normal (D1D2) or slightly reduced (D1HD3) affinity, indicating that a high ligand-affinity may be achieved by a combination of D1 with domain D2 or D3.

KW - GPI-anchored protein

KW - uPA

KW - Urokinase receptor

UR - http://www.scopus.com/inward/record.url?scp=0030026674&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030026674&partnerID=8YFLogxK

U2 - 10.1016/0014-5793(96)00033-6

DO - 10.1016/0014-5793(96)00033-6

M3 - Article

C2 - 8641412

AN - SCOPUS:0030026674

VL - 381

SP - 1

EP - 6

JO - FEBS Letters

JF - FEBS Letters

SN - 0014-5793

IS - 1-2

ER -

Removal of domain D2 or D3 of the human urokinase receptor does not affect ligand affinity

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this